Valuation: Medicure Inc.

Market Cap 11.06M 7.82M 6.84M 6.31M 5.83M 746M 11.25M 75.42M 29.62M 368M 29.38M 28.74M 1.26B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 8.12M 5.74M 5.02M 4.63M 4.28M 548M 8.26M 55.35M 21.74M 270M 21.56M 21.09M 927M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day-17.83%
1 week-17.83%
Current month-17.83%
1 month+1.92%
3 months-13.11%
6 months-8.62%
Current year-7.02%
1 week 1.06
Extreme 1.06
1.06
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 92 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-21Buy

Chief Executive Officer

2,500 0.0240%
06-21Buy

Chief Executive Officer

1,000 0.0096%
06-21Buy

Chief Executive Officer

200 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-17.83%-17.83%-13.82%-7.83% 7.81M
-4.14%-7.44%+64.26%+119.36% 56.98B
+1.84%+1.65%+76.90%+95.68% 53.58B
-2.98%+3.20%+19.09%+464.26% 25.63B
-0.52%-2.45%-19.57%-14.71% 23.51B
+2.43%+5.86%+46.56%+0.42% 19.43B
-3.19%0.00%+33.99%-26.87% 18.12B
-6.84%+2.18%+203.03%+348.11% 16.46B
+8.74%+10.46%+47.66% - 14.13B
+0.88%+2.11%+25.53%+197.33% 14.35B
Average -2.42%-0.74%+48.36%+130.64% 24.22B
Weighted average by Cap. -1.06%+0.29%+56.61%+138.39%

Financials

2024 2025
Net sales 21.91M 15.49M 13.55M 12.5M 11.55M 1.48B 22.28M 149M 58.65M 728M 58.17M 56.91M 2.5B 28.86M 20.41M 17.85M 16.47M 15.21M 1.95B 29.34M 197M 77.26M 959M 76.63M 74.96M 3.3B
Net income -1.04M -735K -643K -593K -548K -70.08M -1.06M -7.08M -2.78M -34.53M -2.76M -2.7M -119M -7.1M -5.02M -4.39M -4.05M -3.74M -479M -7.22M -48.39M -19M -236M -18.85M -18.44M -811M
Net Debt -6.32M -4.47M -3.91M -3.6M -3.33M -426M -6.42M -43.07M -16.91M -210M -16.77M -16.41M -722M -2.94M -2.08M -1.82M -1.68M -1.55M -199M -2.99M -20.07M -7.88M -97.83M -7.82M -7.65M -336M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
09/07/26 CA$1.060 -17.83% 200